Énoncé de position de l'AMMI Canada sur le diagnostic de la maladie de Lyme et le traitement des personnes ayant des symptômes persistants attribués à cette maladie

Editorial

AMMI Canada. J Assoc Med Microbiol Infect Dis Can. 2019.

. 2019 Jun 17;4(2):47-50.

doi: 10.3138/jammi.2019.03.17.fr. eCollection 2019 Jun.

No abstract available

Conflict of interest statement

The authors have nothing to disclose.

1. Klempner MS, Baker PJ, Shapiro ED, et al. Treatment trials for post-Lyme disease symptoms revisited. Am J Med. 2013;126(8):665–9. 10.1016/j.amjmed.2013.02.014. Medline: - DOI - PMC - PubMed
1. Marzec NS, Nelson C, Waldron PR, et al. Serious bacterial infections acquired during treatment of patients given a diagnosis of chronic Lyme disease – United States. MMWR Morb Mortal Wkly Rep. 2017;66(23):607–9. 10.15585/mmwr.mm6623a3. Medline: - DOI - PMC - PubMed
1. Wormser GP, Weitzner E, McKenna D, et al. Long-term assessment of health-related quality of life in patients with culture-confirmed early Lyme disease. Clin Infect Dis. 2015;61(2):244–7. 10.1093/cid/civ277. Medline: - DOI - PubMed
1. Wills AB, Spaulding AB, Adjemian J, et al. Long-term follow-up of patients with Lyme disease: longitudinal analysis of clinical and quality-of-life measures. Clin Infect Dis. 2016;62(12):1546–51. 10.1093/cid/ciw189. Medline: - DOI - PMC - PubMed
1. Feder HM, Johnson BJ, O’Connell S, et al. A critical appraisal of “chronic Lyme disease”. N Engl J Med. 2007;357(14):1422–30. 10.1056/NEJMra072023. Medline:. Erratum in: N Engl J Med. 2008;358(10):1084. Corrected at: 10.1056/NEJMx070061. - DOI - DOI - PubMed